Top Transdermal Skin Patches Companies | Market Leaders 2025
13 May, 2025

Transdermal skin patches are sticky patches that administer medication via the skin into the bloodstream over an extended period, providing a non-invasive, controlled delivery of active components. They are usually applied for long-term conditions like pain relief (e.g., fentanyl), nicotine dependence (nicotine patches), and hormone replacement therapy (e.g., estrogen patches). They are also employed for motion sickness, high blood pressure, and certain neurological diseases. Benefits are ease of administration, better compliance with treatment, lower gastrointestinal side effects, and constant absorption as compared to oral or injectable formulations. Consequently, the market for transdermal skin patches is increasing due to the need for non-invasive delivery of drugs. The transdermal skin patches market globally is anticipated to grow from US$8.05 billion in 2024 to US$10.97 billion in 2033, expanding at a compound annual growth rate (CAGR) of 3.50% during 2025-2033.

The Asia Pacific market for transdermal skin patches is witnessing high growth because of the growing demand for non-invasive drug delivery systems. These patches provide an easy and efficient means of drug delivery, enhancing patient compliance and reducing side effects. The growth in the market is fueled by the increasing incidence of chronic diseases like diabetes, hypertension, and pain management, where transdermal patches are being used increasingly. Moreover, technological advancements in patch technology and increased awareness about personalized medicine also drive the growth in the market. These include countries such as Japan, China, and India, which are market leaders, with increasing emphasis on healthcare infrastructure and drug delivery system innovations.

Favorable regulatory environments and rising healthcare expenditure in the region also underpin the future growth of the market. Asia Pacific transdermal skin patches market is anticipated to increase from US$ 2.76 billion in 2024 to US$ 3.96 billion by 2033 at a CAGR of 4.10% from 2025 to 2033. Drivers are increasing incidence of chronic conditions, growing elderly population, need for pain-free drug delivery, advances in technology, enhancing healthcare infrastructure, and raising awareness regarding self-administered therapy for improved patient compliance and convenience. Teva Pharmaceutical Industries Ltd

Discover key trends, growth opportunities, and major challenges shaping the Global Transdermal Skin Patche Industry in Renub Research’s latest in-depth market report. Download your free sample now

List of Leading Transdermal Patch Manufacturers

Teva Pharmaceutical Industries Ltd

Founding: 1901

Head Office: Israel

Website: www.tevapharm.com

Teva Pharmaceutical Industries Ltd. (Teva) is a multinational pharma company engaged in the development, manufacture, and marketing of generic and innovative pharmaceutical products.

The company's main activities involve the manufacturing of generic drugs, biosimilars, and innovative therapies for diseases like central nervous system disorders, neurodegenerative diseases, movement disorders, dermatology, women's health, respiratory diseases, oncology (including leukemia and some non-Hodgkin's lymphoma subtypes), and other diseases. Teva distributes its drugs in a range of forms, such as capsules, tablets, injectables, liquids, inhalers, creams, and ointments, and also OTC products. It has a large emphasis on the creation of generic drugs and has operations in North America, Europe, and other global markets through subsidiaries. 3M Company

3M Company

Founded: 1902

Headquarters: United States of America

Website: www.3m.com

3M (M Co) is an international producer and distributor of industrial products and solutions.

Its product offerings consist of advanced materials, display materials and systems, home care, home improvement, stationery and office supplies, personal safety, roofing granules, and closure and masking systems, among others. 3M further offers a variety of solutions in medical, oral care, consumer healthcare, food safety, and health information systems, among others. The company caters to customers in different industries, such as automotive, electronics, healthcare, safety, energy, and consumer goods. With manufacturing and converting plants in the Americas, Asia Pacific, Europe, and Middle East and Africa, 3M is a global player. Nitto Denko Corporation

Nitto Denko Corporation

Founding: 1918

Head Office: Japan

Website: www.nitto.com/jp/ja

Nitto Denko Corp (Nitto), a subsidiary of Secomo Co Ltd, is an electrical insulating materials manufacturer and electronics, industrial, and functional products manufacturer.

The firm has expertise in polymer synthesis, adhesive, and coating technology, producing value-added products like optical films for LCDs, automotive materials, membrane products, surface protective films, and double-sided tapes. Nitto also delivers medical solutions, such as surgical athletic tapes, transdermal drug delivery patches, adhesive tapes, and particles for nucleic acid synthesis. Operating in industries like transportation, home appliances, infrastructure, materials, electrical, packaging, and medical devices, Nitto has global sales offices, manufacturing facilities, and R&D laboratories to facilitate its global market presence. Johnson & Johnson

Johnson & Johnson

Formation: 1886

Head Office: United States of America

Website: www.jnj.com

Johnson & Johnson (J&J) is a global healthcare company engaged in research, development, manufacture, and sale of innovative pharmaceuticals and medical devices.

Trading under its subsidiaries, J&J sells pharmaceuticals aimed at treating immune disorders, cancer, neurological diseases, infectious diseases, and cardiovascular and metabolic diseases. The company also sells medical devices employed in cardiovascular, orthopedic, neurovascular treatment, general surgery, and vision correction. J&J sells its products to retailers, wholesalers, hospitals, and healthcare practitioners. With production plants in the US, Europe, Asia-Pacific, Africa, the Western Hemisphere (apart from the US), and Latin America, J&J has a dominant international presence.

Luye Pharma Group

Founded:  1994

Head office: Hong Kong

Website: www.luye.cn/lvye

Luye Pharma Group Ltd (Luye Pharma), a member of Luye Life Sciences Group Ltd, is a drug company that specializes in discovering, producing, and marketing innovative formulations, generic medicines, and pharmaceutical drugs.

The firm sells a broad product portfolio, consisting of tablets, injectable doses, capsules, gels, anti-psychotic drugs, and modified-release formulations, catering to therapeutic spaces like oncology, cardiovascular conditions, orthopedics, hepatology, gastroenterology, gynecology, diabetes, and central nervous system (CNS) disease. Luye Pharma has its research and development and manufacturing facilities in the US, China, and other geographies across the world.

Bayer

Founding: 1863

Headquarters: Germany

Website: www.bayer.com

Bayer AG (Bayer) is a multinational company with an objective of discovering, developing, making, and marketing products to advance human health and agriculture.

It sells drugs for diseases like cardiovascular disorders, women's health, cancer, hematology, ophthalmology, and other therapeutic indications. Bayer also engages in the research of new molecules and technologies for medicine and modern agriculture. Its portfolio of products comprises prescription drugs, specialty pharmaceuticals, diagnostic imaging systems, over-the-counter (OTC) products, seeds, crop protection products, and non-agricultural pest control products. Bayer sells its products through wholesalers, pharmacies, hospitals, and retailers. It has operations in subsidiaries in Asia-Pacific, Europe, North America, Latin America, Africa, and the Middle East.

Novartis AG

Formation: 1996

Head office: Switzerland

Website: www.novartis.com

Novartis AG (Novartis) is a multinational pharmaceutical corporation engaged in the research, development, production, distribution, marketing, and sale of new medicines.

The company has a broad portfolio of products in areas of therapeutic interest including cardiovascular, renal and metabolic, immunology, ophthalmology, respiratory, global health, neuroscience, and oncology. Novartis sells its products under brands such as Entresto, Cosentyx, Kesimpta, Kisqali, and Tasigna, among others, to a wide range of pharmacists, healthcare professionals, government institutions, and insurance organizations across the globe. The company has manufacturing plants in the US, Switzerland, Austria, Slovenia, China, France, and Italy.

Beiersdorf AG

Founding: 1882

Headquarters: Germany

Website: www.beiersdorf.de

Beiersdorf AG (Beiersdorf) is a firm engaged in the development and marketing of skin and body care products.

Its broad product range comprises deodorants, face and body care, sun protection, anti-aging skincare, lip care, wound care, hand and hair care, and self-adhesive products for industrial, craft, and consumer applications. Beiersdorf's popular brands are NIVEA, Eucerin, La Prairie, Labello, Hansaplast, Florena, 8X4, Coppertone, HIDROFUGAL, Tesa, SKIN STORIES, and Gammo. Beiersdorf supplies different industries, such as automotive, electrical engineering, electronics, printing, paper, construction, and pharmaceuticals. Beiersdorf is headquartered in Europe but has its businesses spread all around the globe including Europe, North America, Latin America, Middle East, Africa, and Asia-Pacific.

Viatris Inc.

Year established: 2020

HQ: United States

Website: https://www.viatris.com/en

Viatris Inc. (Viatris) is an international health company that designs, licenses, develops, produces, markets, and distributes generic drugs and brand products, in addition to consumer health products.

The firm provides a broad portfolio of pharmaceuticals in diverse forms to treat conditions like respiratory, cardiovascular, central nervous system (CNS) diseases, allergies, skin conditions, and cancer. Viatris also offers anti-retrovirals, anaphylaxis therapy, and active pharmaceutical ingredients (APIs). The firm markets its products through retail pharmacy chains, wholesalers, distributors, group purchasing organizations, drug stores, independent pharmacies, drug manufacturers, institutions, and government and public agencies. Viatris distributes its products internationally, covering several countries.

Abbott Laboratories

Formation: 1888

Headquarters: United States of America

Website: www.abbott.com

Abbott Laboratories (Abbott) is a worldwide healthcare and medical devices company engaged in discovering, developing, making, and selling a variety of products. The company mainly sells products in the segments of gastroenterology, women's health, cardiovascular and metabolic health, pain management, central nervous system disorders, respiratory drugs and vaccines, biosimilars, and core laboratory and transfusion medicine systems. Abbott also offers point-of-care systems, rapid diagnostic tests, informatics and automation solutions, nutritional products, rhythm management, electrophysiology, heart failure treatments, vascular and structural heart products, and neuromodulation devices. Its products are sold to end customers by wholesalers, distributors, health care facilities, government agencies, pharmacies, and independent retailers in North America, Latin America, Middle East, Europe, Asia-Pacific, and Africa.